Table 3.
First-line chemotherapy for de novo stage IV breast cancer (n = 387).
Chemotherapy regimen | n (%) |
Anthracyclines + paclitaxel | 221 (51.7) |
Paclitaxel | 61 (15.7) |
Paclitaxel + platinum | 38 (9.8) |
Capecitabine + paclitaxel | 34 (8.9) |
Cyclophosphamide + anthracyclines | 21 (5.4) |
Others | 12 (3.1) |